K

Ysios Capital logo

Ysios Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

1

Common Fundraising Type

Series B

Adcendo logo
Adcendo

Biotech • Antibody-Drug Conjugates

TCGX logo
Ysios Capital logo
Venrock Healthcare Capital Partners logo
Surveyor Capital logo

Adcendo is a biotech company focused on developing antibody-drug conjugates for treating cancers with high unmet needs.

Series B
$135M
11/25/2024
Article